Caribou Biosciences at a Crossroads: CRISPR Pioneer Navigates Financial Storm as Clinical Pipeline Stalls
In a development that has sent shockwaves through the biotech sector, Caribou Biosciences (Nasdaq: CRBU)—the Berkeley-based genome-editing powerhouse co-founded by...
